VANGUARD ASSET MANAGEMENT, Ltd
Position in BSX — Boston Scientific Corp
CIK 1680208
London, EC4N 8AF, X0
Position in BSX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$122,627,791
-$38,457,420 QoQ
Shares Held
2,873,191
+11.9% QoQ
Ownership
0.198%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BSX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026VANGUARD ASSET MANAGEMENT, Ltd holds $1,296,085,735 across 41 Medical Devices names. BSX ranks #4 (9.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
3,921,702 | $355,855,239 | |
| 2 | MDT |
Medtronic plc
|
2,891,131 | $226,173,178 | |
| 3 | SYK |
Stryker Corp
|
674,424 | $212,335,652 | |
| 4 | BSX |
Boston Scientific Corp
This page
|
2,873,191 | $122,627,791 | |
| 5 | EW |
Edwards Lifesciences Corp
|
1,111,236 | $100,522,408 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
881,507 | $56,425,263 | |
| 7 | DXCM |
Dexcom Inc
|
741,928 | $49,968,850 | |
| 8 | STE |
STERIS plc
|
191,300 | $40,282,041 |
All Filings in BSX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $122,627,791 | 2,873,191 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $161,085,211 | 2,567,095 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||